Preparation and in vitro Studies of Stealth PEGylated PLGA Nanoparticles as Carriers for Arsenic Trioxide* * Supported by the Special Funds for Major State Basic Research Program of China (973 Program, No. 2007CB935800) and the National High Technology Research and Development Program of China (863 Program, No.2004AA215162).

Chinese Journal of Chemical Engineering

Volumn 15, Issue 6, 2007, Pages 795-801

  WANG, Zhiqing ^a   LIU, Wei ^b   XU, Huibi ^a   YANG, Xiangliang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NONE

Author keywords

arsenic trioxide; in vitro drug release; PEGylated PLGA nanoparticles; phagocytic uptake; ring opening polymerization; spontaneous emulsification solvent diffusion method

Indexed keywords

AMORPHOUS ALLOYS; COPOLYMERS; DRUG DELIVERY; GLYCOLS; NANOPARTICLES; RING OPENING POLYMERIZATION;

ARSENIC TRIOXIDE; PEGYLATED PLGA NANOPARTICLES; PHAGOCYTIC UPTAKE; SPONTANEOUS EMULSIFICATION SOLVENT DIFFUSION METHOD;

ARSENIC COMPOUNDS;

AMORPHOUS ALLOYS; ARSENIC COMPOUNDS; COPOLYMERS; DRUG DELIVERY; GLYCOLS; NANOPARTICLES; RING OPENING POLYMERIZATION;

EID: 38049090504     PISSN: 10049541     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1004-9541(08)60005-1     Document Type: Article

References (26)

1. Chen Z., Chen G.Q., Shen Z.X., Chen S.J., and Wang Z.Y. "Treatment of acute promyelocytic leukemia with arsenic compounds: In vitro and in vivo studies". Seminars in Hematology 38 1 (2001) 26-36
2. Evens A.M., Tallman M.S., and Gartenhaus R.B. "The potential of arsenic trioxide in the treatment of malignant disease: Past, present, and future". Leukemia Research 28 9 (2004) 891-900
3. Snider T.H., Wientjes M.G., Joiner R.L., and Fisher G.L. "Arsenic distribution in rabbits after Lewisite administration and treatment with British anti-Lewisite (BAL)". Fundam Appl. Toxicol. 14 (1990) 262-272
4. Patlolla A.K., and Tchounwou P.B. "Cytogenetic evaluation of arsenic trioxide toxicity in Sprague-Dawley rats". Mutation Research/Genetic Toxicology and Environmental Mutagenesis 587 (2005) 126-133
5. 3 in rabbits: Evidence of reversible chronic toxicity and tissue accumulation of arsenicals after parenteral administration". Toxicol. Appl. Pharm. 189 3 (2003) 214-220
6. 3) in the treatment of acute promyelocytic leukemia (APL) (II) Clinical efficacy and pharmacokinetics in relapsed patient". Blood 89 (1997) 3354-3360
7. Pott W.A., Benjamin S.A., and Yang R.S. "Pharmacokinetics, metabolism, and carcinogenicity of arsenic". Rev. Environ. Contam. Toxicol. 169 (2001) 165-214
8. Soppimath K.S., Aminabhavi T.M., Kulkarni A.R., and Rudzinski W.E. "Biodegradable polymeric nanoparticles as drug delivery devices". J. Control. Release. 70 1/2 (2001) 1-20
9. Pan J.Z., Zhang L.J., and Qian Y. "Structure-property relationships and models of controlled drug delivery of biodegradable poly (D, L-lactic acid) microspheres". Chin. J. Chem. Eng. 12 6 (2004) 869-876
10. Gref R., Luck M., Quellec P., Marchand M., Dellacherie E., Harnisch S., Blunk T., and Muller R.H. "'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): Influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption". Colloid. Surf. B: Biointerf. 18 3/4 (2000) 301-313
11. Peracchia M.T., Gref R., Minamitake Y., Domb A., Lotan N., and Langer R. "PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: Investigation of their drug encapsulation and release characteristics". J. Control. Release 46 3 (1997) 223-231
12. Achim G., Peter S.P., Lucke A., Lu L., and Mikos A.G. "Modulation of marrow stromal cell function using poly (D, L-lactic acid)--poly (ethylene glycol)-monomethyl ether surfaces". J. Biomed. Mat. Res. 46 3 (1999) 390-398
13. Yang A.S., Liu W., Yang L., Li Z.Y., Xu H.B., and Yang X.L. "Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: Preparation and in vitro evaluation". Int. J. Pharm. 331 1 (2007) 123-132
14. Vonarbourg A., Passirani C., Saulnier P., and Benoit J.P. "Parameters influencing the stealthiness of colloidal drug delivery systems". Biomaterials 27 (2006) 4356-4373
15. Avgoustakis K., Beletsi A., Panagia Z., Klepetsanisa P., Karydasb A.G., and Ithakissios D.S. "PLGA-mPEG nanoparticles of cisplatin: In vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties". J. Control. Release 79 (2002) 123-135
16. Li Y.P., Pei Y.Y., Zhang X.Y., Gu Z.H., Zhou Z.H., Yuan W.F., Zhou J.J., Zhu J.H., and Gao X.J. "PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats". J. Control. Release 71 2 (2001) 203-211
17. An J., and Chen Z. The Handbook of Inorganic Compound (1997), Synthesize, Chemical Industry Press, Beijing
18. Murakami H., Kobayashi M., Takeuchi H., and Kawashima Y. "Further application of a modified spontaneous emulsification solvent diffusion method to various types of PLGA and PLA polymers for preparation of nanoparticles". Powder Technol. 107 1/2 (2000) 137-143
19. Feng S.S., and Huang G. "Effects of emulsifiers on the controlled release of paclitaxel [Taxol(R)] from nanospheres of biodegradable polymers". J. Control. Release 71 1 (2001) 53-69
20. Hans M.L., and Lowman A.M. "Biodegradable nanoparticles for drug delivery and targeting". Curr. Opin. Solid State Mat Sci. 6 4 (2002) 319-327
21. Zambaux M.F., Bonneaux F., Gref R., Maincent P., Dellacherie E., Alonso M.J., Labrude P., and Vigneron C. "Influence of experimental parameters on the characteristics of poly (lactic acid) nanoparticles prepared by a double emulsion method". J. Control. Release 50 1-3 (1998) 31-40
22. Douglas S.J., Illum L., and Davis S.S. "Particle size and size distribution of poly (butyl 2-cyanoacrylate) nanoparticles (II) Influence of stabilizers". J. Colloid. Interface Sci. 103 1 (1985) 154-163
23. Fresta M., Cavallaro G., Giammona G., Wehrli E., and Puglisi G. "Preparation and characterization of poly-ethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs". Biomaterials 17 8 (1996) 751-758
24. Fuente H.D., Portales-Pérez D., Baranda L., Díaz-Barriga F., Saavedra-Alanís V., Layseca E., and González-Amaro R. "Effect of arsenic, cadmium and lead on the induction of apoptosis of normal human mononuclear cells". Clin. Exp. Immunol. 129 (2002) 8-14
25. Scholer N., Olbrich C., Tabatt K., Muller R.H., Hahn H., and Liesenfeld O. "Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages". Int. J. Pharm. 221 1/2 (2001) 57-67
26. Gref R., Babak V., Bouillot P., Lukina I., Bodorev M., and Dellacherie E. "Interfacial and emulsion stabilizing properties of amphiphilic water-soluble poly (ethylene glycol)-poly (lactic acid) copolymers for the fabrication of biocompatible nanoparticles". Colloid. Surf. A: Physicochem. Eng. Aspects 143 2/3 (1998) 413-420